These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 20719375

  • 1. Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia.
    Kim HR, Jun CD, Lee YJ, Yang SH, Jeong ET, Park SD, Park DS.
    J Allergy Clin Immunol; 2010 Oct; 126(4):880-882.e6. PubMed ID: 20719375
    [No Abstract] [Full Text] [Related]

  • 2. Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases.
    Park YJ, Oh EJ, Park JW, Kim M, Han K.
    Ann Clin Lab Sci; 2006 Oct; 36(3):262-6. PubMed ID: 16951266
    [Abstract] [Full Text] [Related]

  • 3. [Eosinophil granule protein].
    Hirai K.
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():794-6. PubMed ID: 15658452
    [No Abstract] [Full Text] [Related]

  • 4. [Tissue hypereosinophilia].
    Desreumaux P, Wallaert B, Janin A.
    Rev Prat; 2000 Mar 15; 50(6):630-5. PubMed ID: 10808320
    [Abstract] [Full Text] [Related]

  • 5. Eosinophil cationic protein in patients with fascioliasis: its probable effects on symptoms and signs.
    Demirci M, Kaya S, Cetin ES, Aridogan BC, Korkmaz M.
    Scand J Infect Dis; 2006 Mar 15; 38(5):346-9. PubMed ID: 16709536
    [Abstract] [Full Text] [Related]

  • 6. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity.
    Kim CK, Callaway Z, Fletcher R, Koh YY.
    J Asthma; 2010 Jun 15; 47(5):568-73. PubMed ID: 20560830
    [Abstract] [Full Text] [Related]

  • 7. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P.
    Br J Dermatol; 2006 Jun 15; 154(6):1112-7. PubMed ID: 16704642
    [Abstract] [Full Text] [Related]

  • 8. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.
    Turk J Pediatr; 2009 Jun 15; 51(5):460-5. PubMed ID: 20112601
    [Abstract] [Full Text] [Related]

  • 9. Changes in serum eosinophil cationic protein levels after exercise challenge in asthmatic children.
    Hsieh CC, Goto H, Kobayashi H, Chow WC, Peng WH, Tang RB.
    J Asthma; 2007 Sep 15; 44(7):569-73. PubMed ID: 17885861
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU, Plötz S, Simon D, Seitzer U, Braathen LR, Menz G, Straumann A, Dummer R, Levi-Schaffer F.
    Eur J Immunol; 2003 Apr 15; 33(4):834-9. PubMed ID: 12672048
    [Abstract] [Full Text] [Related]

  • 11. Correlation of eosinophil cationic protein with severity of asthma.
    Badar A, Saeed W, Hussain MM, Aslam M.
    J Ayub Med Coll Abbottabad; 2004 Apr 15; 16(3):66-71. PubMed ID: 15631377
    [Abstract] [Full Text] [Related]

  • 12. Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome?
    Confalonieri M, Tacconi F, De Amici M, Maccario R, Porta C, Gioglio L, Bobbio-Pallavicini E.
    Haematologica; 1995 Apr 15; 80(1):50-3. PubMed ID: 7758993
    [Abstract] [Full Text] [Related]

  • 13. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
    Jin JJ, Butterfield JH, Weiler CR.
    J Allergy Clin Immunol Pract; 2015 Apr 15; 3(6):920-5. PubMed ID: 26342744
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome.
    Tabata R, Tabata C, Katashima Y, Yasumizu R.
    Int Immunopharmacol; 2013 Aug 15; 16(4):488-91. PubMed ID: 23669338
    [Abstract] [Full Text] [Related]

  • 15. [Practical approach to hypereosinophilia].
    Roufosse F, Cogan E.
    Rev Med Brux; 2008 Sep 15; 29(4):400-8. PubMed ID: 18949995
    [Abstract] [Full Text] [Related]

  • 16. Clinical approach to the patient with blood eosinophilia.
    Di Stefano F, Amoroso A.
    Eur Ann Allergy Clin Immunol; 2005 Dec 15; 37(10):380-6. PubMed ID: 16528901
    [Abstract] [Full Text] [Related]

  • 17. [Estimation of eosinophilia, immunoglobulin E and eosinophilic cationic protein concentration during the treatment of toxocariasis].
    Niedworok M, Sordyl B, Borecka A, Gawor J, Małecka-Panas E.
    Wiad Parazytol; 2008 Dec 15; 54(3):225-30. PubMed ID: 19055065
    [Abstract] [Full Text] [Related]

  • 18. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
    Kim YJ, Prussin C, Martin B, Law MA, Haverty TP, Nutman TB, Klion AD.
    J Allergy Clin Immunol; 2004 Dec 15; 114(6):1449-55. PubMed ID: 15577851
    [Abstract] [Full Text] [Related]

  • 19. [Solid focal lesions in the lungs as first sign of hypereosinophilic syndrome].
    Omernik A, Targowski T, Płusa T, Dudko S.
    Pol Merkur Lekarski; 2009 Sep 15; 27(159):229-31. PubMed ID: 19827736
    [Abstract] [Full Text] [Related]

  • 20. [Association of hyponatremia and eosinophilia: correlated idiopathic hypereosinophilic syndrome and SIADH or adrenal insufficiency with secondary eosinophilia].
    Caliandro D, Bulfoni A.
    Clin Ter; 2003 Sep 15; 154(2):131-4. PubMed ID: 12856373
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.